Breast Cancer Publications

A 12-gene genomic instability signature predicts clinical outcomes in multiple cancer types.
Mettu RK, Wan YW, Habermann JK, Ried T, Guo NL.
Int J Biol.Markers. 2010;25(4)

PMC3155635.

A population-based gene signature is predictive of breast cancer survival and chemoresponse.
Rathnagiriswaran S, Wan YW, Abraham J, Castranova V, Qian Y, Guo NL.
Int J Oncol. 2010;36(3):607-616.

PMC3103999.

A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types.
Wan YW, Qian Y, Rathnagiriswaran S, Castranova V, Guo NL.
Oncol.Rep. 2010;24(2):489-494.

PMC3095949.

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome.
Habermann JK, Doering J, Hautaniemi S, Roblick UJ, Bundgen NK, Nicorici D, Kronenwett U, Rathnagiriswaran S, Mettu RK, Ma Y, Kruger S, Bruch HP, Auer G, Guo NL, Ried T.
Int J Cancer. 2009;124(7):1552-1564.

PMC2707256.

Individualized survival and treatment response predictions for breast cancers using phospho-EGFR, phospho-ER, phospho-HER2/neu, phospho-IGF-IR/In, phospho-MAPK, and phospho-p70S6K proteins.
Guo NL, Abraham J, Flynn DC, Castranova V, Shi XL, Qian Y.
Int.J.Biol.Markers. 2007;22(1):1-11.


Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y, Qian Y, Wei L, Abraham J, Shi XL, Castranova V, Harner EJ, Flynn DC, Guo NL.
Clin.Cancer Res. 2007;13(7):2014-2022.